AGIO vs UNH

AGIO exhibits severe financial instability as evidenced by a critical Piotroski F-Score of 1/9, indicating a significant deterioration in fundamental health. While the company maintains an exceptionally strong liquidity position (Current Ratio 11.46) and minimal debt, it is plagued by massive operating losses (-608.89% margin) and an astronomical Price-to-Sales ratio of 30.88. Despite strong top-line revenue growth of 86.10% and bullish analyst targets, the combination of consistent earnings misses, bearish insider selling by the CEO and CFO, and a failing deterministic scorecard suggests the stock is fundamentally overvalued and high-risk.

UnitedHealth Group presents a conflicted profile with a stable but mediocre Piotroski F-Score of 4/9 and a significant disconnect between current price ($323.48) and defensive fair value (Graham Number: $175.91). While revenue growth remains robust at 12.3%, the company has suffered a catastrophic collapse in YoY earnings growth (-99.9%), suggesting severe short-term headwinds or one-time accounting shocks. Technical trends are currently bearish (0/100), though a recent one-month bounce and a favorable Forward P/E of 16.08 indicate analyst expectations of a recovery. The stock is currently trading at a significant premium to its intrinsic value, relying heavily on its market dominance and future earnings normalization.